Use of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents

Archives of Pediatrics and Adolescent Medicine

Volumn 163, Issue 4, 2009, Pages 389-391

  Daniels, Stephen R ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; CHILD; DIABETES MELLITUS; DRUG MISUSE; DRUG USE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

ADOLESCENT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS; DRUG UTILIZATION; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; PRESCRIPTION DRUGS; SEX FACTORS; UNITED STATES;

EID: 64349097543     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2008.575     Document Type: Article

References (15)

1. American Heart Association. Heart Disease and Stroke Statistics: 2007 Update. Dallas, TX: American Heart Association; 2007.
2. Buse JB, Ginsberg HN, Bakris GL, et al; American Heart Association, American Diabetes Association. Primary prevention of cardiovascular disease in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007;30(1):162-172.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (AdultTreatment Panel III). JAMA. 2001;285(19):2486-2497.
4. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC7 report. JAMA. 2003;289(19):2560-2572.
5. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-2398.
6. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264(23):3018-3024.
7. Newman WP, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986;314(3):138-144.
8. Ogden CL, Carroll MD, Fiegal KM. High body mass index for age among US children and adolescents, 2003-2006. JAMA. 2008;299(20):2401-2405.
9. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5, pt 1):608-615.
10. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488-1496.
11. Ford ES, Mokdad AH, Ajani UA. Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics. 2004;114 (6):1534-1544.
12. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3, pt 2):525-584.
13. Liberman JN, Berger JE, Lewis M. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med. 2009;162(4):357-364.
14. Wise PH. The future pediatrician: the challenge of chronic illness. J Pediatr. 2007;151(5)(suppl):S6-S10.
15. de Ferranti S, Ludwig DS. Storm overstatins-the controversy surrounding pharmacologic treatment of children. N Engl J Med. 2008;359(13):1309- 1312.